King Group

IMB researchers have teamed up to develop precise, personalised drugs for epilepsy patients

The assassin bug lies in wait in plants, poised to ambush its prey. Related to cicadas and aphids, it has a large appetite, catching any unsuspecting invertebrates, like caterpillars or bees, for its next meal.

The first-ever drug to treat heart attack and protect donor hearts will now move to human clinical trials

The ‘electric caterpillar’ is a public menace to gardeners in Townsville and the North-East of Australia but IMB researchers are looking beyond their painful stings to their potential as sources for new medicines and insecticides.

A molecule sourced from funnel web spider venom shows promise as a safe and effective drug for heart attacks.

Professor Glenn King has been awarded the prestigious prize for his work in developing a sustainable way to increase food production.

Find out the results of our weekly poll to find out what scares and fascinates us most!

IMB researchers have transformed fear into something more positive with their venom research.

Did you know venom – a toxic substance injected by one animal into another – has evolved around 100 times?